References

nid

Нефрология и диализ

Nephrology and Dialysis

1680-44222618-9801

Российское диализное общество

nid-3721

Research Article

ОБЗОРЫ И ЛЕКЦИИ

REVIEWS AND LECTURES

Адекватность гемодиализа. Классический подход

Adequacy of hemodyalisis. Classical approach

Земченков

А. Ю.

Zemtchenkov

A. U.

noemail@neicon.ru

Центр передовых медицинских технологий, Санкт-ПетербургRussian Federation

2001

28062025

31420

2025

Земченков А.Ю.

Zemtchenkov A.U.

Данная работа распространяется под лицензией Creative Commons Attribution 4.0.

This work is licensed under a Creative Commons Attribution 4.0 License.

https://journal.nephro.ru/jour/article/view/3721

Введение Адекватность диализа - понятие, не поддающееся строгому и жестко очерченному определению - слишком многообразны мнения специалистов. Можно, однако, определить область параметров, которые могут (либо не могут) адекватно регулироваться диализом. Очевидно, что диализ никогда не будет полностью удовлетворять всем потребностям организма, которые обеспечиваются нормально функционирующими почками. Однако сделать диализ адекватным его возможностям замещения ряда важнейших функций почек мы обязаны. Адекватным диализным лечением можно назвать такое, которое ликвидирует все признаки и симптомы уремии и полностью реабилитирует больного. Многие стороны этой проблемы, такие как доза диализа, белково-энергетическая недостаточность, податливость пациента, биосовместимость, водный баланс, повторное использование диализаторов и пр. могут иметь большее или меньшее отношение к вопросу. Но основными тремя составляющими, по которым диализ должен быть адекватным, то есть соответствовать своим возможностям, по-видимому, являются:

адекватность диализаадекватность питаниябелково-энергетическая недостаточностьоценка БЭНадекватность водного баланса

References1

Барановский А.Ю., Шостка Г.Д., Райхельсон К.Л., Эйдельштейн В.А., Земченков А.Ю., Гаврик С.Л., Дмитриева Г.Ю., Герасимчук Р.П. Белково-энергетическая недостаточность у больных с терминальной стадией хронической почечной недостаточности, корригируемой различными видами заместительной терапии. Нефрология и диализ 1999; 10.

Земченков А.Ю., Кондуров С.В., Гаврик С.Л., Райхельсон К.Л., Эйдельштейн В.А. Качество жизни пациентов с хронической почечной недостаточностью, корригируемой заместительной терапией. Нефрология и диализ 1999; 1(2-3): 118-127.

Земченков А.Ю., Райхельсон К.Л., Эйдельштейн В.А. Нутриционный статус у больных на перитонеальном диализе. Нефрология и диализ 2000; 2 (1-2): 85-94.

Кучер А.Г. Проблемы лечебного питания у больных с хронической почечной недостаточностью. Нефрология 1997; 1 (1): 39-46.

Charra B., Calemard E., Cuche M., Laurent G. Control of hypertension and prolonged survival on maintenance hemodialysis. Nephron 1983; 33: 96-99.

Charra B., Calemard E., Ruffet M., Chazot C., Terrat J.C., Vanel T., Laurent G. Survival as an index of adequacy of dialysis. Kidney Int 1992; 41(5): 1286-1291.

Chertow G.M., Owen W.F., Lazarus J.M., Lew N.L., Lowrie E.G. The interplay of uremia and malnutrition: An hypothesis for the reverse J-shaped curve between URR and mortality. Kidney Int 1999; 56: 1872-1878.

Collins A.J., Ma J.Z., Umen A., Keshaviah P. Urea index and other predictors of hemodialysis patient survival. Am J Kidney Dis 1994; 23(2): 272-282.

Coyne D.W., Delmez J., Spence G., Windus D.W. Impaired delivery of hemodialysis prescriptions: an analysis of causes and an approach to evaluation J Am Soc Nephrol 1997; 8(8): 1315-8.

Daugirdas J.T. Second generation logarithmic estimates of single-pool variable volume Kt-V: An analysis of error. J Am Soc Nephrol 1993; 4: 1205-1213.

Daugirdas J.T. Estimation of equilibarated Kt/V using the unequilibrated post dialysis BUN. Sem Dial 1995; 8: 283-284.

Depner T.A., Keshaviah P.R., Ebben J.P., Emerson P.F., Collins A.J., Jindal K.K., Nissenson A.R., Lazarus J.M., Pu K. Multicenter clinical validation of an on-line monitor of dialysis adequacy. J Am Soc Nephrol 1996; 7: 464-471.

Depner T.A., Daugirdas J.T. Equations for normalized protein catabolic rate based on two-point modeling of hemodialysis urea kinetics. J Am Soc Nephrol 1996; 7: 780-785.

Depner T.A., Beck G., Daugirdas J., Kusek J., Eknoyan G. Lessons From the Hemodialysis (HEMO) Study: An Improved Measure of the Actual Hemodialysis Dose. Am J Kidney Dis 1999; 33 (1): 142-149.

Frankenfield D.L., McClellan W.M., Helgerson S.D., Lowrie E.G., Rocco M.V., Owen W.F. Relationship between urea reduction ratio, demographic characteristics, and body weight in the 1996 National ESRD Core Indicators Project. Am J Kidney Dis 1999; 33: 584-591.

Giordano C., Esposito R., De Pascale C. Dietary treatment in renal failure. Proc. III Int. Congress of Nephrology 1966; 3: 214-229.

Giovanetti S. Diet in cronic uremia. Proc. III Int. Congress of Nephrology 1966; 3: 230-236.

Gotch F.A., Sargent J.A. A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int. 1985; 28(3): 526-534.

Gotch F.A. Kinetic modeling in hemodialysis. In Nissenson AR, Fine RN, Gentile DE (eds): Clinical Dialysis. 8. (ed 3rd) Englewood Cliffs, NJ, Prentice Hall, 1995, pp 156-189.

Gotch F.A., Levin N.W., Port F.K., Wolfe R.A., Uehlinger D.E. Clinical outcome relative to the dose of dialysis is not what you think: The fallacy of the mean. Am J Kidney Dis 1997; 30: 1-15.

Hakim R.M., Breyer J., Ismail N., Schulman G. Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis 1994; 23: 661-669.

Held P.J., Brunner F., Odaka M., Garcia J.R., Port F.K., Gaylin D.S. Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982 to 1987. Am J Kidney Dis. 1990; 15(5): 451-457.

Held et al. J Am Soc Nephrol 1991; 2: 328.

Held P.J., Port F.K., Wolfe R.A., Stannard D.C., Carroll C.E., Daugirdas J.T., Greer J.W., Hakim R.M. The dose of hemodialysis and patient mortality. Kidney Int 1996; 50: 550-556.

Hornberger J.C. The hemodialysis prescription and quality-adjusted life expectancy. J Am Soc Nephrol 1993; 4: 1004-1020.

Ikizler T.A., Greene J.H., Wingard R.L., Parker R.A., Hakim R.M. Spontaneous dietary protein intake during progression of chronic renal failure. J Am Soc Nephrol 1995; 6(5): 1386-91.

Jaeger J.Q., Mehta R.L. Assessment of Dry Weight in Hemodialysis: An Overview. J Am Soc Nephrol 1998; 10(2): 98-104.

Kasiske B.L., Lakatua J.D.A., Ma J.Z., Louis T.A. A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. Am J Kidney Dis 1998; 31: 954-961.

Kaysen G.A., Stevenson F.T., Depner T.A. Determinants of albumin concentration in hemodialysis patients. Am J Kidney Dis 1997; 29(5): 658-68.

Klahr S., Levey A.S., Beck G.J., Caggiula A.W., Hunsicker L., Kusek J.W., Striker G. for the Modification of Diet in Renal Disease Study Group: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med 1994; 330: 877-884.

Kopple J.D., Zhu X., Lew N.L., Lowrie E.G. Body weight-for-height percentile relationships predict mortality in maintenance hemodialysis patients. Kidney Int 1999; 56: 1136-1148.

Kouw P.M., Kooman J.P., Cheriex E.C., Olthof C.G., de Vries P.M.J.M., Leunissen K.M.L. Assessment of postdialysis dry weight: A comparison of techniques. J Am Soc Nephrol 1993; 4: 98-104.

Lameire N. When do we begin dialysis therapy? - ASN 1997 Satellite Symposium: Patient referral and dialysis initiation practices: A European perspective. http://www.hdcn.com.

Leblanc M., Charbonneau R., Lalumiere G., Cartier P., Deziel C. Postdialysis urea rebound: Determinants and influence on dialysis delivery in chronic hemodialysis patients. Am J Kidney Dis 1996; 27: 253-261.

Levey A.S., Green T., Beck G.J., Caggiula A.W., Kusek J.W., Hunsicker L.G., Klahr S. Dietary Protein Restriction and the Progression of Chronic Renal Disease: What Have All of the Results of the MDRD Study Shown? J Am Soc Nephrol 1999; 10(11): 328.

Li Z., Nancy L., Lew N.L., Lazarus J.M., Lowrie E.G. Comparing the Urea Reduction Ratio and the Urea Product as Outcome-Based Measures of Hemodialysis Dose Am J Kidney Dis 2000; 35(4): 598-605.

Lins R.L., Elseviers M., Rogiers P., Van Hoeywegen R.J., De Raedt H., Zachee P., Daelemans R.A. Importance of volume factors in dialysis-related hypertension. Clin Nephrol 1997; 48: 29-33.

Lowrie E.G., Laird N.M., Parker T.F., Sargent J.A. Effect of the hemodialysis prescription on patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med. 1981; 305(20): 1176-1181.

Lowrie E.G., Lew N.L. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990; 15: 458-482.

Lowrie E.G., Zhu X., Lew N.L. Primary associates of mortality among dialysis patients: Trends and reassessment of Kt/V and urea reduction ratio as outcome-based measures of dialysis dose. Am J Kidney Dis 1998; 32 (suppl 4): S16-S32.

Lowrie E.G. Indexing physiological measurements to body size: A common practice that should be changed. Semin Dial 1999; 12 (suppl 1): S55-S60.

Lowrie E.G., Chertow G.M., Lew N.L., Lazarus J.M., Owen W.F. The {clearance x time} product (Kt) as an outcome-based measure of dialysis dose. Kidney Int 1999; 56: 729-737.

McCusker F.X., Teehan B.P., Thorpe K.E., Keshaviah P.R., Churchill D.N. How much peritoneal dialysis is required for the maintenance of a good nutritional state? Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Kidney Int. 1996; Suppl 50: S56-61.

Mehrotra R., Nolph K.D. Treatment of advanced renal failure: Low protein diet or timely initiation of dialysis? Kidney Int. 2000; 58(4): 1381-1388.

NKF-DOQI Clinical Practice Guidelines for Hemodialysis Adequacy. NKF-DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy. Am J Kidney Dis 1997; 30(3) Suppl 2: S1-S135.

NKF-DOQI Clinical Practice Guidelines for Nutrition in Chronic Renal Failure. http://www.kidney.org/professionals/doqi/doqi/doqi_nut.html.

Owen W.F., Lew N.L., Liu Y., Lowrie E.G., Lazarus J.M. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993; 329: 1001-1006.

Pedrini L.A., Zereik S., Rasmy S. Causes, kinetics and clinical implications of post-hemodialysis urea rebound. Kidney Int 1988; 34: 817-824.

Ronco С. Opinions regarding outcome differences in European and US haemodialysis patients [news]. Nephrol Dial Transplant. 1999; 14(11): 2616-20.

Schneditz D., Van Stone J.C., Daugirdas J.T. A regional blood circulation alternative to in-series two compartment urea kinetic modeling. ASAIO J 1993; 39:M573-M577.

Smye S.W., Dunderdale E., Brownridge G., Will E. Estimation of treatment dose in high-efficiency haemodialysis. Rev Enferm 1994; 67: 24-29.

Steuer R.R., Harris D.H., Conis J.M. A new optical technique for monitoring hematocrit and circulating blood volume: Its application in renal dialysis. Dial Transplant 1993; 22: 260-265.

Tattersall J., Farrington K., Bowser M., Aldridge C., Greenwood R.N., Levin N.W. Underdialysis caused by reliance on single pool urea kinetic modeling. J Am Soc Nephrol 1996; 3: 398.

Teraoka S., Toma H., Nihei H. et al. Current status of renal replacement therapy in Japan. Am J Kidney Dis 1995; 25: 151-164.

United States Renal Data System: 1997 Annual Data Report. U.S. Department of Health and Human Service, Public Health Service, National Institute of Healht, Bethesda, 1997.

United States Renal Data System: USRDS 1999 Annual Data Report. National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Disease. Bethesda, 1999.

Wolfe R.A., Ashby V.B., Daugirdas J.T., Agodoa L.Y.C., Jones C.A., Port F.K. Body size, dose of hemodialysis and mortality. Am J Kidney Dis 2000; 35: 80-88.

Перевод на русский язык статьи: Wolfe R.A., Ashby V.B., Daugirdas J.T., Agodoa L.Y.C., Jones C.A., Port F.K. Body size, dose of hemodialysis and mortality. Am J Kidney Dis 2000; 35: 80-88 см. Российское Диализное Общество. Web-сайт//www.dialysis.ru.

The authors declare that there are no conflicts of interest present.